Cutaneous warts

Clinics in Dermatology

Volumn 15, Issue 3, 1997, Pages 309-319

  Jabłońska, Stefania ^a   Majewski, Slawomir ^a   Obalek, Slawomir ^a   Orth, Gérard ^a  

^a Klinika Dermatologiczna Medical University of Warsaw   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMODYSPLASIA VERRUCIFORMIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; VERRUCA VULGARIS; VIRUS CELL INTERACTION; VIRUS STRAIN; WART VIRUS;

EID: 0343035578     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(96)00170-8     Document Type: Article

References (65)

1. Gissmann L, Pfister H, zur Hausen H. Human papilloma viruses (HPV): Characterization of four different isolates. Virology 1977;76:569-80.
2. Orth G, Favre M, Croissant O. Characterization of a new type of human papillomavirus that causes skin warts. J Virol 1977;24:108-20.
3. Orth G, Jablonska S, Favre M, et al. Characterization of two new types of HPV from lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci (NY) 1978;75:1537-41.
4. Jablonska S, Orth G, Obalek S, et al. Cutaneous warts, clinical, histologic and virologic correlations. Clin Dermatol 1985; 3:71-82.
5. Chen S-L, Tsao YP, Lee JW, et al. Characterization and analysis of human papillomaviruses of skin warts. Arch Dermatol Res 1993;285:460-5.
6. Larsson PA, Liden S. Prevalence of skin diseases among adolescents 12-16 years of age. Acta Derm Venereol (Stockh) 1980;60:415-23.
7. Williams HC, Pottier A, Strachan D. The descriptive epidemiology of warts in British schoolchildren. Br J Dermatol 1993;128:504-11.
8. Currie IM, Wright RC, Miller OG. The frequency of warts in atopic patients. Cutis 1971;8:243-45.
9. Williams H, Pottier A, Strachan D. Are viral warts seen more commonly in children with eczema? Arch Dermatol 1993;129:717-21.
10. Skurkovich SV, Eremkina EJ. The probable role of interferon in allergy. Ann Allergy 1975;35:356-60.
11. Blohme I, Larko O. Skin lesions in renal transplant patients after 10-23 years of immunosuppressive therapy. Acta Derm Verereol (Stockh) 1990;70:491-4.
12. Dyall-Smith D, Trowell H, Dyall-Smith ML. Benign human papillomavirus infection in renal transplant recipients. Int J Dermatol 1991;30:785-9.
13. Proby CM, Shamanin IV, Rausch C. Novel human papillomavirus identified in skin cancers from renal transplant recipients. Br J Dermatol 1995;132:644.
14. Jablonska S, Obalek S, Golebiowska A, et al. Epidemiology of butchers' warts. Arch Dermatol Res 1988;280:S24-8.
15. Keefe M, Al-Ghamdi A, Coggon D, et al. Cutaneous warts in butchers. Br J Dermatol 1994;130:9-14.
16. Chan SY, Delius H, Halpern AL, et al. Analysis of genomic sequences of 95 papillomavirus types: uniting, typing, phylogeny, and taxonomy. J Virol 1995;69:3074-83.
17. van Ranst M, Kaplan JB, Burk RD. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol 1992;73:2653-60.
18. de Villiers E-M. Heterogenity of the human papillomavirus group. J Virol 1989; 63:4898-903.
19. de Villiers E-M. Human pathogenic papillomaviruses. An update. Curr Top Microbiol Immunol 1994;86:1-12.
20. Jablonska S, Orth G. Butchers' warts. Br J Dermatol 1995; 132:166-7.
21. Orth G. Human papillomaviruses: general features. In: Webster RG and Granhoff A, editors. Encyclopedia of virology, vol. 2. London: Academic Press, 1994:1013-21.
22. Pfister H, zur Hausen H. Seroepidermiological studies of human papillomavirus (HPV1) infections. Int J Cancer 1978;21:161-5.
23. Carter JJ, Hogenesee M, Taflin MC. HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts. Virol 1993;195:456-62.
24. Rogel-Gaillard C, Breitburd F, Orth G. Human papillomavirus type 1 E4 proteins differing by their N-terminal ends have distinct cellular localizations when transiently expressed in vitro. J Virol 1992;66:816-23.
25. Obalek S, Jablonska S, Favre M, et al. Condylomata acuminata in children: Frequent association with human papillomaviruses responsible for cutaneous warts. J Am Acad Dermatol 1990;23:205-13.
26. Cohen BA, Honig P, Androphy E. Anogenital warts in children: clinical and virological evaluation for sex abuse. Arch Dermatol 1990;126:1575-80.
27. Kwittken J. Signet ring verruca. Mt Sinai J Med 1976;43: 61-5.
28. Melchers W, de Mare S, Kuitert E, et al. Human papillomavirus and cutaneous warts in meat handlers. J Clin Microbiol 1993;31:2547-9.
29. Orth G, Jablonska S, Favre M, et al. Identification of papillomaviruses in butchers' warts. J Invest Dermatol 1981; 76:97-102.
30. Oltersdorf T, Camp MS, Favre M, et al. Molecular cloning and characterization of human papillomavirus type 7 DNA. Virology 1986;149:247-50.
31. Jablonska S, Obalek S, Favre M, et al. The morphology of butchers' warts as related to papillomavirus types. Arch Dermatol Res 1987;279:S66-72.
32. Maitland NJ, Keefe M, Al-Ghamdi A, et al. Human papillomavirus type 7 and the butcher's wart. Papillomavirus Rep 1995;6:33-7.
33. Fox AJ, Lynge E, Malker H. Lung cancer in butchers. Lancet 1982:165-6.
34. Al-Ghamdi AA, Sanders CM, Keefe M, et al. Human papillomaviruses DNA and TP53 mutations in lung cancers from butchers. Br J Cancer 1995;72:293-7.
35. de Villiers E-M, Neumann C, Oltersdorf T, et al. Butcher's wart virus (HPV 7) infections in non-butchers. J Invest Dermatol 1986;87:236-8.
36. Greenspan D, de Villers E-M, Greenspan JS, et al. Unusual HPV types in oral warts in association with HIV infection. J Oral Pathol 1988;17:482-8.
37. de Villiers E-M. Prevalence of HPV-7 papillomas in the oral mucosa and facial skin of patients with human immunodeficiency virus. Arch Dermatol 1989;125:1590.
38. Matsukara T, Iwasaki T, Kawashima M. Molecular cloning of a novel human papillomavirus (type 60) from a plantar cyst with characteristic pathological changes. Virology 1992;190:561-4.
39. Kawase M, Honda M, Niimura M. Detection of human papillomavirus type 60 in plantar cysts and verruca plantaris by the in situ hybridization method using digoxigenin labeled probes. J Dermatol 1994;21:709-15.
40. Egawa K, Inaba Y, Yoshimura K, et al. Varied clinical morphology of HPV-1-induced warts, depending on anatomical factors. Br J Dermatol 1993;128:271-6.
41. Egawa K. New types of human papillomaviruses and intracytoplasmic inclusion bodies: a classification of inclusion warts according to clinical features, histology and associated HPV types. Br J Dermatol 1994;130:158-66.
42. Egawa K. New types of human papillomaviruses and intracytoplasmic inclusion bodies: a classification of inclusion warts according to clinical features, histology and associated HPV types. Br J Dermatol 1994;130:158-66.
43. Rios-Buceta LM, Fraga-Fernandez J, Fernandez-Herrera J. Human papillomavirus in an epidermoid cyst of the sole in a non-Japanese patient. J Am Acad Dermatol 1992;27:364-6.
44. Rose RC, Reichman RC, Bonnez W. Human papillomavirus type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J Gen Virol 1994;75:2075-81.
45. Christensen ND, Kirnbauer R, Schiller JT, et al. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology 1994;205:309-15.
46. Naples SP, Brodell RT. Verruca vulgaris: treatment with natural interferon alfa using a needless injector. Arch Dermatol 1993;129:698-700.
47. Beissert S, Koch U, Sunderkotter C, et al. Successful treatment of disseminated verrucae vulgares with interferon-b. J Am Acad Dermatol 1993;29:1041-2.
48. Schofer H, Sollberg S. Systemic treatment of common warts with beta-interferon. Hautarzt 1991;42:396-8.
49. van der Steen P, van de Kerkhof P, der Kindern D, et al. Clinical and immunohistochemical responses of plantar warts to topical immunotherapy with diphenylcyclopropenone. J Dermatol 1991;18:330-3.
50. Iljima S, Otsuka F. Contact immunotherapy with squarid acid dibutylester for warts. Dermatology 1993;187:115-8.
51. Coleman N, Birley HDL, Renton AM, et al. Immunological events in regressing genital warts. Am J Clin Pathol 1994;102:768-74.
52. Morelli AE, Belardi G, DiPaolo G, et al. Cellular subsets and epithelial ICAM-1 and HLA-DR expression in human papillomavirus infection of the vulva. Acta Derm Venereol (Stockh) 1994;74:45-9.
53. Majewski S, Breitburd F, Orth G, et al. Regulation of MHC class I, class II and ICAM-1 expression by cytokines and retinoids in HPV-harboring keratinocyte lines. In: Stanley MA, editors. Immunology of human papillomaviruses. New York: Plenum Press, 1994:207-10.
54. Wu R, Coleman N, Higgins G, et al. Lymphocyte-mediated cytotoxicity to HPV 16 infected cervical keratinocytes. In: Stanley MA, editor. Immunology of human papillomaviruses. New York: Plenum Press, 1994:225-9.
55. Jablonska S, Orth G, Lutzner MA. Immunopathology of papillomaviruses induced tumors in different tissues. Springer Semin Immunopathol 1982;5:33-62.
56. Majewski S, Skopinska-Rozewska E, Jablonska S, et al. Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 1986;15:966-73.
57. Charleson FC, Norval M, Benton EC, et al. Lymphoproliferative responses to human papillomaviruses in patients with cutaneous warts. Br J Dermatol 1992;127:551-9.
58. Steele JC, Stankovic T, Gallimore PH. Production and characterization of human proliferative T-cell clones specific for human papillomavirus type 1 E4 protein. J Virol 1993;67:2799-806.
59. Schröder J-M. Cytokine networks in the skin. J Invest Dermatol 1995;105:20S-4S.
60. Rösl F, Lengert M, Albrecht J, et al. Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids. J Virol 1994;68:2142-50.
61. Guidi AJ, Abu-Jawdeh G, Berse B, et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 1995;87:1237-45.
62. Malejczyk J, Malejczyk M, Köck A, et al. Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor-a. J Immunol 1992;149:2702-8.
63. Haftek M, Jablonska S, Orth G. Specific cell mediated immunity in patients with epidermodysplasia verruciformis and plane warts. Dermatologica 1985;170:213-20.
64. Rogozinski T, Jablonska S, Jarzabek-Chorzelska M. Role of cell-mediated immunity in spontaneous regression of plane warts. Int J Dermatol 1988;27:322-6.
65. Malejczyk J, Malejczyk M, Majewski S, et al. NK-cell activity in patients with HPV16-associated anogenital tumors: defective recognition of HPV 16-harboring keratinocytes and restricted unresponsiveness to immunostimulatory cytokines. Int J Cancer 1993;54:917-21.